Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1223-1225, 2003; 10.1373/49.7.1223
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harmoinen, A.
Right arrow Articles by Saha, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harmoinen, A.
Right arrow Articles by Saha, H.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2003;49:1223-1225.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

Diagnostic Accuracies of Plasma Creatinine, Cystatin C, and Glomerular Filtration Rate Calculated by the Cockcroft–Gault and Levey (MDRD) Formulas

Aimo Harmoinen1,a, Terho Lehtimäki1,2,5, Markku Korpela3, Väinö Turjanmaa4 and Heikki Saha2,3

1 Centre of Laboratory Medicine,
3 Department of Internal Medicine, and
4 Department of Clinical Physiology, Tampere University Hospital, FIN-33521 Tampere, Finland

2 Tampere University Medical School, FIN-33521 Tampere, Finland

5 Laboratory of Atherosclerosis Genetics, FIN-33520 Tampere, Finland

aaddress correspondence to this author at: Centre of Laboratory Medicine, Tampere University Hospital, PO Box 2000, FIN-33521 Tampere, Finland; e-mail aimo.harmoinen@tays.fi

The first 20% of the full text of this article appears below.

Estimation of the glomerular filtration rate (GFR) is the most widely used test of renal function, reflecting the relative mass of functional renal tissue and thus the number of functioning nephrons. Methods based on measurement of exogenous substances such as inulin, 51Cr-EDTA, 99mTc-diethylenetriaminepentaacetic acid, and iohexol are accurate but too complex and laborious for routine clinical use; thus, measurement of endogenous blood substances is common practice. Plasma or serum creatinine and its renal clearance are the approaches most commonly used despite their acknowledged unreliability.

Cystatin C, a small basic protein, has been proposed as a better marker than creatinine. Recently, the value of cystatin C was thoroughly reviewed in this Journal (1), and according to this review and a new metaanalysis (2), most studies have concluded that cystatin C is superior to plasma creatinine, whereas several authors have concluded that cystatin C provides no advantage. One purpose of the present study was to clarify possible reasons for the earlier, partly conflicting results.

A recently published guideline from the National Kidney Foundation (3) recommended that GFR be estimated from prediction equations taking into account the serum creatinine concentration and some or all of the following variables: age, gender, race, and body size. We therefore also compared cystatin C with GFRs calculated by the Cockcroft–Gault (4) and the MDRD(5) formulas.

We studied 112 patients (55 men and 57 women) for whom 51Cr-EDTA clearance had been requested. The mean age of the patients was 57.0 years (range, 17–89 years). Body mass . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Circ Heart FailHome page
M. D. McMurray, J. E. Trivax, and P. A. McCullough
Serum Cystatin C, Renal Filtration Function, and Left Ventricular Remodeling
Circ Heart Fail, March 1, 2009; 2(2): 86 - 89.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. S. MacGregor
How common is early chronic kidney disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease
Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix8 - ix18.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
J. H.Y. Wu, N. C. Ward, A. P. Indrawan, C.-A. Almeida, J. M. Hodgson, J. M. Proudfoot, I. B. Puddey, and K. D. Croft
Effects of {alpha}-Tocopherol and Mixed Tocopherol Supplementation on Markers of Oxidative Stress and Inflammation in Type 2 Diabetes
Clin. Chem., March 1, 2007; 53(3): 511 - 519.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Kuitunen, A. Vento, R. Suojaranta-Ylinen, and V. Pettila
Acute Renal Failure After Cardiac Surgery: Evaluation of the RIFLE Classification
Ann. Thorac. Surg., February 1, 2006; 81(2): 542 - 546.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. J. Brugts, A. M. Knetsch, F. U. S. Mattace-Raso, A. Hofman, and J. C. M. Witteman
Renal Function and Risk of Myocardial Infarction in an Elderly Population: The Rotterdam Study
Arch Intern Med, December 12, 2005; 165(22): 2659 - 2665.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. N. Sambrook, J. S. Chen, L. M. March, I. D. Cameron, R. G. Cumming, S. R. Lord, J. Schwarz, and M. J. Seibel
Serum Parathyroid Hormone Is Associated with Increased Mortality Independent of 25-Hydroxy Vitamin D Status, Bone Mass, and Renal Function in the Frail and Very Old: A Cohort Study
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5477 - 5481.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.